http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Sakaguchi, Takahiro,Jeon, Il,Chiba, Takaaki,Shawky, Ahmed,Xiang, Rong,Chiashi, Shohei,Kauppinen, Esko I.,Park, Nam-Gyu,Matsuo, Yutaka,Maruyama, Shigeo Cambridge University Press (Materials Research Soc 2018 MRS Communications Vol.8 No.3
<▼1><B>Abstract</B><P/></▼1><▼2><P>Lead halide perovskite solar cells (PSCs) with a structure of glass/FTO/TiO2/CH3NH3PbI3 with single-walled carbon nanotubes (SWNT) as the transparent top electrodes, followed by polymethyl methacrylate (PMMA) over-coating were fabricated. The SWNT-based PSCs do not require expensive metal electrodes and hole-transporting materials yet produce a decent power conversion efficiency of 11.8%, owing to the densifying effect of SWNTs by PMMA. The resulting devices demonstrate reduced hysteresis, improved stability, and increased power conversion efficiency.</P></▼2>
Radiotherapy for locally recurrent rectal cancer treated with surgery alone as the initial treatment
Hidekazu Tanaka,Takahiro Yamaguchi,Kae Hachiya,Sunaho Okada,Masashi Kitahara,Katsuya Matsuyama,Masayuki Matsuo 대한방사선종양학회 2017 Radiation Oncology Journal Vol.35 No.1
Purpose: Although the technical developments of radiotherapy have been remarkable, there are currently few reports on the treatment results of radiotherapy for local recurrence of rectal cancer treated with surgery alone as initial treatment in this three-dimensional conformal radiotherapy era. Thus, we retrospectively evaluated the treatment results of radiotherapy for local recurrence of rectal cancer treated with surgery alone as the initial treatment. Materials and Methods: Thirty-two patients who underwent radiotherapy were enrolled in this study. The dose per fraction was 2.0–3.5 Gy. Because the treatment schedule was variable, the biological effective dose (BED) was calculated. Results: Local control (LC) and overall survival (OS) rates from the completion of radiotherapy were calculated. The 1-, 2-, 3-, 4-, and 5-year LC rates were 51.5%, 24.5%, 19.6%, 19.6%, and 13.1%, respectively. LC rates were significantly higher for the high BED group (≥75 Gy10) than for the lower BED group (<75 Gy10). All patients who reported pain achieved pain relief. The duration of pain relief was significantly higher for the high BED group than for the lower BED group. The 1-, 2-, 3-, 4-, and 5-year OS rates were 82.6%, 56.5%, 45.2%, 38.7%, and 23.2%, respectively. There was a trend toward higher OS rates in with higher BED group compared to lower BED group. Conclusion: For patients with unresectable locally recurrent rectal cancer treated with surgery alone, radiotherapy is effective treatment. The prescribed BED should be more than 75 Gy10, if the dose to the organ at risk is within acceptable levels.
Radiotherapy for locally recurrent rectal cancer treated with surgery alone as the initial treatment
Tanaka, Hidekazu,Yamaguchi, Takahiro,Hachiya, Kae,Okada, Sunaho,Kitahara, Masashi,Matsuyama, Katsuya,Matsuo, Masayuki The Korean Society for Radiation Oncology 2017 Radiation Oncology Journal Vol.35 No.1
Purpose: Although the technical developments of radiotherapy have been remarkable, there are currently few reports on the treatment results of radiotherapy for local recurrence of rectal cancer treated with surgery alone as initial treatment in this three-dimensional conformal radiotherapy era. Thus, we retrospectively evaluated the treatment results of radiotherapy for local recurrence of rectal cancer treated with surgery alone as the initial treatment. Materials and Methods: Thirty-two patients who underwent radiotherapy were enrolled in this study. The dose per fraction was 2.0-3.5 Gy. Because the treatment schedule was variable, the biological effective dose (BED) was calculated. Results: Local control (LC) and overall survival (OS) rates from the completion of radiotherapy were calculated. The 1-, 2-, 3-, 4-, and 5-year LC rates were 51.5%, 24.5%, 19.6%, 19.6%, and 13.1%, respectively. LC rates were significantly higher for the high BED group (${\geq}75Gy_{10}$) than for the lower BED group (<$75Gy_{10}$). All patients who reported pain achieved pain relief. The duration of pain relief was significantly higher for the high BED group than for the lower BED group. The 1-, 2-, 3-, 4-, and 5-year OS rates were 82.6%, 56.5%, 45.2%, 38.7%, and 23.2%, respectively. There was a trend toward higher OS rates in with higher BED group compared to lower BED group. Conclusion: For patients with unresectable locally recurrent rectal cancer treated with surgery alone, radiotherapy is effective treatment. The prescribed BED should be more than $75Gy_{10}$, if the dose to the organ at risk is within acceptable levels.
Yasuyuki Nakamura,Daisuke Hokuto,Fumikazu Koyama,Yasuko Matsuo,Takeo Nomi,Takahiro Yoshikawa,Naoki Kamitani,Tomomi Sadamitsu,Takeshi Takei,Yayoi Matsumoto,Yosuke Iwasa,Kohei Fukuoka,Shinsaku Obara,Tak 대한대장항문학회 2021 Annals of Coloproctolgy Vol.37 No.5
Purpose: Primary tumor location of colon cancer has been reported to affect the prognosis after curative resection. However, some reports suggested the impact was varied by tumor stage. This study analyzed the prognostic impact of the sidedness of colon cancer in stages II, III, and liver metastasis after curative resection using propensity-matched analysis.Methods: Right-sided colon cancer was defined as a tumor located from cecum to splenic flexure, while any more distal colon cancer was defined as left-sided colon cancer. Patients who underwent curative resection at Nara Medical University hospital between 2000 and 2016 were analyzed.Results: There were 110 patients with stage II, 100 patients with stage III, and 106 patients with liver metastasis. After propensity matching, 28 pairs with stage II and 32 pairs with stage III were identified. In the patients with stage II, overall survival (OS) and recurrence-free survival (RFS) were not significantly different for right- and left-sided colon cancers. In the patients with stage III, OS and RFS were significantly worse in right-sided colon cancer. In those with liver metastasis, OS of right-sided colon cancer was significantly worse than left-sided disease, while RFS was similar. Regarding metachronous liver metastasis, the difference was observed only in the patients whose primary colon cancer was stage III. In each stage, significantly higher rate of peritoneal recurrence was found in those with right-sided colon cancer.Conclusion: Sidedness of colon cancer had a significant and varied prognostic impact in patients with stage II, III, and liver metastasis after curative resection.